Vaping cessation has emerged as a critical public health goal, particularly among teens and young adults who are increasingly falling into the trap of nicotine addiction.Recent research indicates that utilizing FDA-approved treatments like varenicline can significantly enhance the chances of quitting vaping, with participants experiencing three times greater success compared to those relying solely on behavioral counseling.
Varenicline has emerged as a beacon of hope in the battle against nicotine addiction, especially among teens and young adults grappling with vaping habits.This FDA-approved smoking cessation medication has demonstrated remarkable effectiveness, with clinical trials revealing that participants using varenicline were over three times more successful in quitting vaping compared to those relying solely on behavioral counseling.